| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.06 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.08 | 0.07 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.07 |